Gorka
Pérez-Yarza Pérez-Irezábal
Hospital Universitario de Cruces
Barakaldo, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Cruces (6)
2020
-
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study
Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718
2011
-
A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene
PLoS ONE, Vol. 6, Núm. 4
-
Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms
Apoptosis, Vol. 16, Núm. 12, pp. 1253-1267
2010
-
Histamine and histamine receptor antagonists in cancer biology
Inflammation and Allergy - Drug Targets, Vol. 9, Núm. 3, pp. 146-157
2009
-
Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma
British Journal of Dermatology, Vol. 160, Núm. 3, pp. 519-526
2006
-
H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells
Carcinogenesis, Vol. 27, Núm. 9, pp. 1787-1796